Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

Inhibitors of protein methyltransferases and demethylases

HU Kaniskan, ML Martini, J Jin - Chemical reviews, 2018 - ACS Publications
Post-translational modifications of histones by protein methyltransferases (PMTs) and
histone demethylases (KDMs) play an important role in the regulation of gene expression …

Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress

ME Neganova, SG Klochkov, YR Aleksandrova… - Seminars in Cancer …, 2022 - Elsevier
Epigenetic changes associated with histone modifications play an important role in the
emergence and maintenance of the phenotype of various cancer types. In contrast to direct …

A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

L Wang, J Chang, D Varghese, M Dellinger… - Nature …, 2013 - nature.com
The pharmacological inhibition of general transcriptional regulators has the potential to
block growth through targeting multiple tumorigenic signalling pathways simultaneously …

Inhibition of 2-oxoglutarate dependent oxygenases

NR Rose, MA McDonough, ONF King… - Chemical Society …, 2011 - pubs.rsc.org
2-Oxoglutarate (2OG) dependent oxygenases are ubiquitous iron enzymes that couple
substrate oxidation to the conversion of 2OG to succinate and carbon dioxide. In humans …

Recent advances of iridium (III) metallophosphors for health-related applications

PY Ho, CL Ho, WY Wong - Coordination Chemistry Reviews, 2020 - Elsevier
Phosphorescent transition metal complexes have been intensively investigated, since these
luminophores are distinctively different from fluorescent chromophores in terms of the nature …

JMJD family proteins in cancer and inflammation

W Manni, X Jianxin, H Weiqi, C Siyuan… - Signal transduction and …, 2022 - nature.com
The occurrence of cancer entails a series of genetic mutations that favor uncontrollable
tumor growth. It is believed that various factors collectively contribute to cancer, and there is …

Advances in histone demethylase KDM4 as cancer therapeutic targets

DH Lee, GW Kim, YH Jeon, J Yoo, SW Lee… - The FASEB …, 2020 - Wiley Online Library
Abstract The KDM4 subfamily H3K9 histone demethylases are epigenetic regulators that
control chromatin structure and gene expression by demethylating histone H3K9, H3K36 …

Recent progress in histone demethylase inhibitors

TE McAllister, KS England, RJ Hopkinson… - Journal of medicinal …, 2016 - ACS Publications
There is increasing interest in targeting histone N-methyl-lysine demethylases (KDMs) with
small molecules both for the generation of probes for target exploration and for therapeutic …

Evolving strategies in the treatment of anaemia in chronic kidney disease: the HIF-prolyl hydroxylase inhibitors

F Locatelli, R Minutolo, L De Nicola, L Del Vecchio - Drugs, 2022 - Springer
Chronic kidney disease (CKD) affects approximately 10% of the worldwide population;
anaemia is a frequent complication. Inadequate erythropoietin production and absolute or …